Thank you to @aktien_max and Simon @topsecretstocks for having our leadership team on the show! Will Heyburn, Melissa Tomkiel and Mat Schneider covered our One-Call Platform, DCD/NRP growth, M&A strategy and the long-term vision for Strata Critical — building the national infrastructure backbone for organ logistics, recovery, placement and transplant. The opportunity is significant. We hope you'll tune in. m.youtube.com/watch?v=Kke1hG…

Great chatting with @spacanpanman and hearing some great questions from our community of individual investors!

Congratulations to @TGHCares on reaching 15,000 transplants! As Tampa General's dedicated logistics partner, we're proud to have played a small role in supporting this incredible milestone. Here's to many more! prnewswire.com/news-releases…

Strata 1Q 2026 organic year-over-year revenue and gross profit growth of 32% and 30% respectively. Clinical sequential revenue and gross profit growth of 13% and 29% respectively. Reiterating 2026 guidance. We will host a conference call at 8am ET.  edge.media-server.com/mmc/p/…

Strata is releasing Q1 2026 earnings tomorrow before market open and will hold a conference call to discuss the results at 8 am ET (link below). If you have questions, please send them to investors@srta.com. register-conf.media-server.c…

Strata's acquisition of Ohio Valley Perfusion Associates reflects our disciplined approach to M&A: accretive bolt-ons in fragmented, recurring-revenue end markets that complement our existing clinical operations. Cardiac perfusion remains a core growth pillar alongside our organ recovery and transplant vertical. Today's Press Release: ir.stratacritical.com/news-e… $SRTA

Groundbreaking research from the University of Pittsburgh shows liver transplant recipients trained to accept donor organs without lifelong immunosuppression. A small study, but a massive signal for the future of transplant medicine. Every advance in transplant outcomes starts with a successful recovery and delivery. That's what we do. nytimes.com/2026/04/17/healt…

Strata is releasing Q1 2026 earnings on May 6th before market open and will hold a call to discuss the results at 8 am ET (link below). If you have questions, we would love to hear from you! Please send them to investors@srta.com, and management will pick several to answer during the call. register-conf.media-server.c…

Check out the link below for a replay of Strata Critical Co-CEO Will Heyburn's discussion with analyst Matt Shea at the 25th Annual Needham Healthcare Conference. summitcast.meetmax.com/view/…

Strata Critical Medical today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 1:30 pm ET. A webcast of the event will be available through the link below. summitcast.meetmax.com/view/…

Approximately 5,000 Americans die every year while waiting for an organ transplant match. Dr. Montgomery, director of the NYU Langone Transplant Institute—himself a heart transplant recipient—is working to change that with gene-edited pig kidneys. This is what "Reimagining the Future of Organ Transplants" looks like. We're proud to support NYU Langone with logistics, organ recovery services, and organ placement. time.com/collection/time-for…

Strata Critical congratulates New England Donor Services on an extraordinary 2025, enabling 1,692 life-saving transplants through innovation, dedication, and operational excellence. We are proud to partner with NEDS, supporting donation opportunities that utilize Normothermic Regional Perfusion (NRP). businesswire.com/news/home/2…

LiveOnNY, the Greater New York area OPO, launched a campaign to increase organ donation registration. Strata is a proud partner of New York's largest transplant centers. prnewswire.com/news-releases….

New research from NYU Langone surgeons highlights the increasing number of DCD donors (donation after circulatory death) and the key enablers including normothermic regional perfusion and machine perfusion. nyulangone.org/news/more-org…

Strata 4Q 2025 organic revenue and gross profit growth of 35% and 39% respectively. Full year 2025 revenue and Adj EBITDA both beat the high end of our guidance range. Raising 2026 revenue and Adj EBITDA guidance. We will host a conference call at 8am ET. edge.media-server.com/mmc/p/…

Strata will report 4Q 2025 and full year 2025 results this coming Tuesday March 3rd at 8am ET. If you have a question, we would love to hear from you! Please send your questions to investors@srta.com and management will select several to address on Tuesday's call.